Abstract:ATP-sensitive potassium (K(ATP)) channels are widely distributed in vasculatures, and play an important role in the vascular tone regulation. The K(ATP) channels consist of 4 pore-forming inward rectifier K(+) channel (Kir) subunits and 4 regulatory sulfonylurea receptors (SUR). The major vascular isoform of K(ATP) channels is composed of Kir6.1/SUR2B, although low levels of other subunits are also present in vascular beds. The observation from transgenic mice and humans carrying Kir6.1/SUR2B channel mutations strongly supports that normal activity of the Kir6.1/SUR2B channel is critical for cardiovascular function. The Kir6.1/SUR2B channel is regulated by intracellular ATP and ADP. The channel is a common target of several vasodilators and vasoconstrictors. Endogenous vasopressors such as arginine vasopressin and α-adrenoceptor agonists stimulate protein kinase C (PKC) and inhibit the K(ATP) channels, while vasodilators such as β-adrenoceptor agonists and vasoactive intestinal polypeptide increase K(ATP) channel activity by activating the adenylate cyclase-cAMP-protein kinase A (PKA) pathway. PKC phosphorylates a cluster of 4 serine residues at C-terminus of Kir6.1, whereas PKA acts on Ser1387 in the nucleotide binding domain 2 of SUR2B. The Kir6.1/SUR2B channel is also inhibited by oxidants including reactive oxygen species allowing vascular regulation in oxidative stress. The molecular basis underlying such a channel inhibition is likely to be mediated by S-glutathionylation at a few cysteine residues, especially Cys176, in Kir6.1. Furthermore, the channel activity is augmented in endotoxemia or septic shock, as a result of the upregulation of Kir6.1/SUR2B expression. Activation of the nuclear factor-κB dependent transcriptional mechanism contributes to the Kir6.1/SUR2B channel upregulation by lipopolysaccharides and perhaps other toll-like receptor ligands as well. In this review, we summarize the vascular K(ATP) channel regulation under physiological and pathophysiological conditions, and discuss the importance of K(ATP) channel as a potentially useful target in the treatment and prevention of cardiovascular diseases.

Research development on the blockers and openers of ATP-sensitive K+channels

Opening of K-ATP Channel Regulates Tonic Currents from Pyramidal Neurons in Rat Brain

ATP-sensitive Potassium Channels and Neuroprotection Study

The ATP-sensitive potassium channel: a therapeutic target for neurodegeneration?

Design, Synthesis and Biological Activities of Benzo[d]imidazo[1,2-A]imidazole Derivatives As TRPM2-specfic Inhibitors

The role of KATP channels in cerebral ischemic stroke and diabetes

[Atp-Sensitive Potassium Channel and Its Cardiovascular Protection Effects].

The Emerging Structural Pharmacology of ATP-Sensitive Potassium Channels

Functional Protection Against Cardiac Diseases Depends On Atp-Sensitive Potassium Channels

Relationship between BKCa channels and cardiovascular diseases

Research progress of mitochondrial ATP-sensitive potassium channels in myocardial protection

Potassium Channels: Structures, Diseases, and Modulators

Structural insights into the mechanism of pancreatic KATP channel regulation by nucleotides

K(ATP) channel action in vascular tone regulation: from genetics to diseases.

Openers of SKCa and IKCa channels enhance agonist-evoked endothelial nitric oxide synthesis and arteriolar vasodilation.

From Basic Physiology to Clinical Applications

Current strategies for the discovery of K+ channel modulators.

Recent progress in the structural biology of P2X receptors

Identification and characterisation of functional Kir6.1‐containing ATP‐sensitive potassium channels in the cardiac ventricular sarcolemmal membrane

KCNT1 Channel Blockers: A Medicinal Chemistry Perspective

Discovery of Potent and Selective Blockers Targeting the Epilepsy-Associated K Na 1.1 Channel